# Nuclide record astrazeneca (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/astrazeneca/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "astrazeneca" ;
  schema:name "AstraZeneca"@en ;
  schema:alternateName "Acerta Pharma"@en, "Alexion Pharmaceuticals"@en, "MedImmune LLC"@en, "MedImmune"@en ;
  schema:description "AstraZeneca is the most ADC-committed large pharma, co-owner of Enhertu and Datroway, with deep targeted-therapy and radiopharma bets."@en ;
  schema:url <https://nuclide.cc/companies/astrazeneca/>, <https://www.astrazeneca.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/AstraZeneca> ;
  owl:sameAs <http://www.wikidata.org/entity/Q731938> ;
  schema:citation <https://www.astrazeneca.com> ;
  schema:addressCountry "GB" ;
  nuclide:related <https://nuclide.cc/isotopes/ac-225/> ;
  nuclide:drugs <https://nuclide.cc/drugs/olaparib/>, <https://nuclide.cc/drugs/durvalumab/>, <https://nuclide.cc/drugs/ac225-psma/>, <https://nuclide.cc/drugs/fpi-2265/> ;
  nuclide:trials <https://nuclide.cc/trials/nct07611110/>, <https://nuclide.cc/trials/nct05219500/>, <https://nuclide.cc/trials/nct07590934/>, <https://nuclide.cc/trials/nct06909825/>, <https://nuclide.cc/trials/nct06040099/> .